These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 15018984)

  • 1. The ophthalmic lyophilisate carrier system (OLCS): development of a novel dosage form, freeze-drying technique, and in vitro quality control tests.
    Süverkrüp R; Grunthal S; Krasichkova O; Maier S; Weichselbaum A; Neff B; Diestelhorst M; Dinslage S; Lux A
    Eur J Pharm Biopharm; 2004 Mar; 57(2):269-77. PubMed ID: 15018984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative bioavailability study of three conventional eye drops versus a single lyophilisate.
    Lux A; Maier S; Dinslage S; Süverkrüp R; Diestelhorst M
    Br J Ophthalmol; 2003 Apr; 87(4):436-40. PubMed ID: 12642306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioavailability of fluorescein from a new drug delivery system in human eyes.
    Steinfeld A; Lux A; Maier S; Süverkrüp R; Diestelhorst M
    Br J Ophthalmol; 2004 Jan; 88(1):48-53. PubMed ID: 14693772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lyophilisates for drug delivery in ophthalmology: pharmacokinetics of fluorescein in the human anterior segment.
    Dinslage S; Diestelhorst M; Weichselbaum A; Süverkrüp R
    Br J Ophthalmol; 2002 Oct; 86(10):1114-7. PubMed ID: 12234889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modelling ocular pharmacokinetics of fluorescein administered as lyophilisate or conventional eye drops.
    Abduljalil K; Diestelhorst M; Doroshyenko O; Lux A; Steinfeld A; Dinslage S; Süverkrüp R; Fuhr U
    Eur J Clin Pharmacol; 2008 May; 64(5):521-9. PubMed ID: 18219479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequential changes of lipid tear film after the instillation of a single drop of a new emulsion eye drop in dry eye patients.
    Di Pascuale MA; Goto E; Tseng SC
    Ophthalmology; 2004 Apr; 111(4):783-91. PubMed ID: 15051213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dry Drops: a new preservative-free drug delivery system.
    Diestelhorst M; Grunthal S; Süverkrüp R
    Graefes Arch Clin Exp Ophthalmol; 1999 May; 237(5):394-8. PubMed ID: 10333106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical freezing rate in freeze drying nanocrystal dispersions.
    Lee J; Cheng Y
    J Control Release; 2006 Mar; 111(1-2):185-92. PubMed ID: 16430987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ophthalmic drug dosage forms: characterisation and research methods.
    Baranowski P; Karolewicz B; Gajda M; Pluta J
    ScientificWorldJournal; 2014; 2014():861904. PubMed ID: 24772038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymeric nanoparticulate system: a potential approach for ocular drug delivery.
    Nagarwal RC; Kant S; Singh PN; Maiti P; Pandit JK
    J Control Release; 2009 May; 136(1):2-13. PubMed ID: 19331856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel procedure for preparation of submicron liposomes-lyophilization of oil-in-water emulsions.
    Wang T; Wang N; Jin X; Zhang K; Li T
    J Liposome Res; 2009; 19(3):231-40. PubMed ID: 19263267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative in vitro investigation of the forces exerted by eye drops and eye spray.
    Müller F; Wagner M; Neubert RH
    Pharmazie; 2005 Aug; 60(8):630-1. PubMed ID: 16124410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative study of treatment of the dry eye syndrome due to disturbances of the tear film lipid layer with lipid-containing tear substitutes].
    Dausch D; Lee S; Dausch S; Kim JC; Schwert G; Michelson W
    Klin Monbl Augenheilkd; 2006 Dec; 223(12):974-83. PubMed ID: 17199193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flexible coils with a drug-releasing hydrophilic coating: a new platform for controlled delivery of drugs to the eye?
    Pijls RT; Hanssen HH; Nuijts RM; Koole LH
    Biomed Mater Eng; 2004; 14(4):383-93. PubMed ID: 15472387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioavailability and anticataract effects of a topical ocular drug delivery system containing disulfiram and hydroxypropyl-beta-cyclodextrin on selenite-treated rats.
    Wang S; Li D; Ito Y; Nabekura T; Wang S; Zhang J; Wu C
    Curr Eye Res; 2004 Jul; 29(1):51-8. PubMed ID: 15370367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promoting effect of borneol on the permeability of puerarin eye drops and timolol maleate eye drops through the cornea in vitro.
    Wu CJ; Huang QW; Qi HY; Guo P; Hou SX
    Pharmazie; 2006 Sep; 61(9):783-8. PubMed ID: 17020156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Freeze drying of human serum albumin (HSA) nanoparticles with different excipients.
    Anhorn MG; Mahler HC; Langer K
    Int J Pharm; 2008 Nov; 363(1-2):162-9. PubMed ID: 18672043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Freeze-drying of Lactobacillus coryniformis Si3--effects of sucrose concentration, cell density, and freezing rate on cell survival and thermophysical properties.
    Schoug A; Olsson J; Carlfors J; Schnürer J; Håkansson S
    Cryobiology; 2006 Aug; 53(1):119-27. PubMed ID: 16756971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dispersion of microemulsion drops in HEMA hydrogel: a potential ophthalmic drug delivery vehicle.
    Gulsen D; Chauhan A
    Int J Pharm; 2005 Mar; 292(1-2):95-117. PubMed ID: 15725557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.